These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 22772764)

  • 1. Histone deacetylases 1 and 3 but not 2 mediate cytokine-induced beta cell apoptosis in INS-1 cells and dispersed primary islets from rats and are differentially regulated in the islets of type 1 diabetic children.
    Lundh M; Christensen DP; Damgaard Nielsen M; Richardson SJ; Dahllöf MS; Skovgaard T; Berthelsen J; Dinarello CA; Stevenazzi A; Mascagni P; Grunnet LG; Morgan NG; Mandrup-Poulsen T
    Diabetologia; 2012 Sep; 55(9):2421-31. PubMed ID: 22772764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysine deacetylases are produced in pancreatic beta cells and are differentially regulated by proinflammatory cytokines.
    Lundh M; Christensen DP; Rasmussen DN; Mascagni P; Dinarello CA; Billestrup N; Grunnet LG; Mandrup-Poulsen T
    Diabetologia; 2010 Dec; 53(12):2569-78. PubMed ID: 20878317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of histone deacetylases prevents cytokine-induced toxicity in beta cells.
    Larsen L; Tonnesen M; Ronn SG; Størling J; Jørgensen S; Mascagni P; Dinarello CA; Billestrup N; Mandrup-Poulsen T
    Diabetologia; 2007 Apr; 50(4):779-89. PubMed ID: 17265033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type-specific roles of histone deacetylase (HDAC) overexpression in ovarian carcinoma: HDAC1 enhances cell proliferation and HDAC3 stimulates cell migration with downregulation of E-cadherin.
    Hayashi A; Horiuchi A; Kikuchi N; Hayashi T; Fuseya C; Suzuki A; Konishi I; Shiozawa T
    Int J Cancer; 2010 Sep; 127(6):1332-46. PubMed ID: 20049841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington's disease.
    Jia H; Pallos J; Jacques V; Lau A; Tang B; Cooper A; Syed A; Purcell J; Chen Y; Sharma S; Sangrey GR; Darnell SB; Plasterer H; Sadri-Vakili G; Gottesfeld JM; Thompson LM; Rusche JR; Marsh JL; Thomas EA
    Neurobiol Dis; 2012 May; 46(2):351-61. PubMed ID: 22590724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein acetylation derepresses Serotonin Synthesis to potentiate Pancreatic Beta-Cell Function through HDAC1-PKA-Tph1 signaling.
    Zhang Y; Wang S; Zhang L; Zhou F; Zhu K; Zhu Q; Liu Q; Liu Y; Jiang L; Ning G; Bi Y; Zhou L; Wang X
    Theranostics; 2020; 10(16):7351-7368. PubMed ID: 32641996
    [No Abstract]   [Full Text] [Related]  

  • 7. Histone deacetylase inhibition by MS-275 potentiates glucose-stimulated insulin secretion without affecting glucose oxidation.
    Zhang Y; Li M; Wang Y; Liu X; Zhou L; Zhang C; Shao L
    Life Sci; 2020 Sep; 257():118073. PubMed ID: 32663574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A toolbox for class I HDACs reveals isoform specific roles in gene regulation and protein acetylation.
    Hess L; Moos V; Lauber AA; Reiter W; Schuster M; Hartl N; Lackner D; Boenke T; Koren A; Guzzardo PM; Gundacker B; Riegler A; Vician P; Miccolo C; Leiter S; Chandrasekharan MB; Vcelkova T; Tanzer A; Jun JQ; Bradner J; Brosch G; Hartl M; Bock C; Bürckstümmer T; Kubicek S; Chiocca S; Bhaskara S; Seiser C
    PLoS Genet; 2022 Aug; 18(8):e1010376. PubMed ID: 35994477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDAC1 and HDAC2 regulate anti-inflammatory effects of anesthetic isoflurane in human monocytes.
    Guo X; Deng J; Zheng B; Liu H; Zhang Y; Ying Y; Jia J; Ruan X
    Immunol Cell Biol; 2020 Apr; 98(4):318-331. PubMed ID: 31950542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDAC inhibitor-mediated beta-cell protection against cytokine-induced toxicity is STAT1 Tyr701 phosphorylation independent.
    Dahllöf MS; Christensen DP; Harving M; Wagner BK; Mandrup-Poulsen T; Lundh M
    J Interferon Cytokine Res; 2015 Jan; 35(1):63-70. PubMed ID: 25062500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HDAC7 is overexpressed in human diabetic islets and impairs insulin secretion in rat islets and clonal beta cells.
    Daneshpajooh M; Bacos K; Bysani M; Bagge A; Ottosson Laakso E; Vikman P; Eliasson L; Mulder H; Ling C
    Diabetologia; 2017 Jan; 60(1):116-125. PubMed ID: 27796421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression.
    Ashburner BP; Westerheide SD; Baldwin AS
    Mol Cell Biol; 2001 Oct; 21(20):7065-77. PubMed ID: 11564889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone deacetylases are critical targets of bortezomib-induced cytotoxicity in multiple myeloma.
    Kikuchi J; Wada T; Shimizu R; Izumi T; Akutsu M; Mitsunaga K; Noborio-Hatano K; Nobuyoshi M; Ozawa K; Kano Y; Furukawa Y
    Blood; 2010 Jul; 116(3):406-17. PubMed ID: 20351311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysine deacetylase inhibition prevents diabetes by chromatin-independent immunoregulation and β-cell protection.
    Christensen DP; Gysemans C; Lundh M; Dahllöf MS; Noesgaard D; Schmidt SF; Mandrup S; Birkbak N; Workman CT; Piemonti L; Blaabjerg L; Monzani V; Fossati G; Mascagni P; Paraskevas S; Aikin RA; Billestrup N; Grunnet LG; Dinarello CA; Mathieu C; Mandrup-Poulsen T
    Proc Natl Acad Sci U S A; 2014 Jan; 111(3):1055-9. PubMed ID: 24395784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDAC inhibition activates the apoptosome via Apaf1 upregulation in hepatocellular carcinoma.
    Buurman R; Sandbothe M; Schlegelberger B; Skawran B
    Eur J Med Res; 2016 Jun; 21(1):26. PubMed ID: 27342975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of histone deacetylase 3 protects beta cells from cytokine-induced apoptosis.
    Chou DH; Holson EB; Wagner FF; Tang AJ; Maglathlin RL; Lewis TA; Schreiber SL; Wagner BK
    Chem Biol; 2012 Jun; 19(6):669-73. PubMed ID: 22726680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of histone deacetylase 3 in adult beta cells improves glucose tolerance via increased insulin secretion.
    Remsberg JR; Ediger BN; Ho WY; Damle M; Li Z; Teng C; Lanzillotta C; Stoffers DA; Lazar MA
    Mol Metab; 2017 Jan; 6(1):30-37. PubMed ID: 28123935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs and histone deacetylase inhibition-mediated protection against inflammatory β-cell damage.
    Lindeløv Vestergaard A; Heiner Bang-Berthelsen C; Fløyel T; Lucien Stahl J; Christen L; Taheri Sotudeh F; de Hemmer Horskjær P; Stensgaard Frederiksen K; Greek Kofod F; Bruun C; Adrian Berchtold L; Størling J; Regazzi R; Kaur S; Pociot F; Mandrup-Poulsen T
    PLoS One; 2018; 13(9):e0203713. PubMed ID: 30260972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Histone Deacetylase Inhibition on the Expression of Multidrug Resistance-associated Protein 2 in a Human Placental Trophoblast Cell Line.
    Duan HY; Ma D; Zhou KY; Wang T; Zhang Y; Li YF; Wu JL; Hua YM; Wang C
    Chin Med J (Engl); 2017 Jun; 130(11):1352-1360. PubMed ID: 28524836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective Inhibition of HDAC1 and HDAC2 as a Potential Therapeutic Option for B-ALL.
    Stubbs MC; Kim W; Bariteau M; Davis T; Vempati S; Minehart J; Witkin M; Qi J; Krivtsov AV; Bradner JE; Kung AL; Armstrong SA
    Clin Cancer Res; 2015 May; 21(10):2348-58. PubMed ID: 25688158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.